ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $231,000 | +29.8% | 19,637 | +13.2% | 0.02% | +90.9% |
| Q4 2018 | $178,000 | -32.8% | 17,345 | +36.3% | 0.01% | -67.6% |
| Q1 2017 | $265,000 | -21.4% | 12,726 | +24.9% | 0.03% | +13.3% |
| Q4 2015 | $337,000 | -80.7% | 10,191 | -80.8% | 0.03% | -80.0% |
| Q3 2015 | $1,742,000 | +229.3% | 53,181 | +431.8% | 0.15% | +154.2% |
| Q2 2015 | $529,000 | -35.2% | 10,000 | -64.7% | 0.06% | -28.9% |
| Q1 2015 | $816,000 | – | 28,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |